Chemical Compound
Valsartan benzyl ester
CAS Registry Number
137863-20-8
Primary Record
Valsartan benzyl ester
- In stock
- 1,517 g
- Purity
- 99.4 %
- CAS
- 137863-20-8
Compound Identifiers & Properties
- CAS
- 137863-20-8
- PubChem CID
- 11283894
- SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)OCC4=CC=CC=C4
- Canonical SMILES
- CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)OCc1ccccc1)C(C)C
Names & Synonyms
- Valsartan benzyl ester
- 137863-20-8
- Diovan
- Valsartan related compound C
- Valsartan EP Impurity B
- Valsartan impurity B
- Valsartan impurity B [EP]
- RefChem:901607
- (S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- 2P0MPU907C
- UNII-2P0MPU907C
- SCHEMBL2691
- MFCD12407184
- Valsartan related compound C [USP]
- DTXSID70160342
- VXKKFWDUSKMRNO-LJAQVGFWSA-N
- C31H35N5O3
- orb1705563
- DTXCID3082833
- SCHEMBL30630285
- CTK8B5686
- Valsartan related compound C RS [USP]
- Valsartan related compound C (USP)
- ANW-49606
- SC1410
- ZINC65749015
- AKOS015854417
- AKOS015899738
- VALSARTAN IMPURITY B [EP IMPURITY]
- ACN-026593
- CB11822
- CS-O-08395
- IO28663
- CID11283894
- EC 604-047-3
- Valsartan related compound C RS (USP)
- AS-78678
- BR-39368
- SY425939
- VALSARTAN RELATED COMPOUND C [USP-RS]
- VALSARTAN IMPURITY B (EP IMPURITY)
- AB0088233
- DB-322107
- TR-005023
- FT-0675773
- J1.195.519C
- L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester
- VALSARTAN RELATED COMPOUND C (USP-RS)
- VALSARTAN RELATED COMPOUND C [USP IMPURITY]
- benzyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate
- S-7513
- VALSARTAN BENZYL ESTER (REFERENCE GRADE)
- A886381
- Benzyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
- VALSARTAN RELATED COMPOUND C (USP IMPURITY)
- Benzyl (2S)-3-methyl-2-(pentanoyl((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)butanoate
- I14-11667
- Q27255284
- L-Valine, N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, phenylmethyl ester
- [(S-N-VALERYL-N-([2'-(1H-TETRAZOLE-5-YL)BIPHEN-4-YL]METHYL)-VALINE BENZYL ESTER)
- 5-[(2-methoxyphenyl)diazenyl]-1,3-diazinane-2,4,6-trione
- B2694-394752
- 1894176-44-3
- Benzyl (2S)-3-methyl-2-(N-((4-(2-(1H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)pentanamido)butanoate
- N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine Phenylmethyl Ester
- (S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate
- BENZYL (2S)-3-METHYL-2-(N-{[2'-(1H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHYL}PENTANAMIDO)BUTANOATE
- benzyl (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate
- Benzyl (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate
- N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]
- [N-Valeryl-N[[2?-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl]-L-valine Benzyl Ester
- Benzyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valinate
- N-(1-Oxopentyl)-N-[2 -(1H-tetrazole-5-yl)biphenyl-4-ylmethyl]-L-valine benzyl ester
- N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-N-valeryl-(L)-valine benzyl ester
- N-Pentanoyl-N-[[2 -(1H-tetrazole-5-yl)biphenyl-4-yl]methyl]-L-valine=benzyl ester
- Valsartan Related Compound C, United States Pharmacopeia (USP) Reference Standard
- (2S)-2-[Pentanoyl[2 -(2H-tetrazole-5-yl)-4-biphenylylmethyl]amino]-3-methylbutyric acid benzyl ester
- (N-VALERYL-N-{[2'-(1HTETRAZOLE-5-YL)BIPHENYL-4-YL]METHYL}-L-VALINEBENZYL ESTER)(Valsartan Related Compound C), Pharmaceutical Secondary Standard; Certified Reference Material
- (s)-benzyl 2-(n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- (S)-Benzyl 2-(N-((2;-(1H-tetrazol-5-yl)-[1,1;-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- (S)-benzyl2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- (S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine
- (S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
- (S)-N-(1-Benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
- 92265-26-4
- benzyl (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate
- Benzyl (S)-2-[N-[[2 inverted exclamation mark -(5-Tetrazolyl)-4-biphenylyl]methyl]pentanamido]-3-methylbutanoate
- L-Valine,N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,phenylmethyl ester
- N-(1-Oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine phenylmethyl ester
- N-[[2 -(1H-Tetrazole-5-yl)-1,1 -biphenyl-4-yl]methyl]-N-pentanoyl-L-valine benzyl ester
- Valsartan Imp. B (EP); Valsartan USP Related Compound C; Valsartan USP RC C; Benzyl (2S)-3-Methyl-2-[pentanoyl-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate, Valsartan Imp B (EP), Valsartan Related Compound C (USP); Valsartan Related Compound C; Valsartan Impurity B